Nature Communications (Jul 2022)

Landscape of somatic alterations in large-scale solid tumors from an Asian population

  • Liqun Wu,
  • Herui Yao,
  • Hui Chen,
  • Aodi Wang,
  • Kun Guo,
  • Wenli Gou,
  • Yanfei Yu,
  • Xiang Li,
  • Ming Yao,
  • Shaohua Yuan,
  • Fei Pang,
  • Jinwei Hu,
  • Lijuan Chen,
  • Wenjin Liu,
  • Jicheng Yao,
  • Shuirong Zhang,
  • Xiaowei Dong,
  • Weifeng Wang,
  • Jing Hu,
  • Qi Ling,
  • Songming Ding,
  • Yan Wei,
  • Qiang Li,
  • Weichun Cao,
  • Shuang Wang,
  • Yang Di,
  • Feiling Feng,
  • Gang Zhao,
  • Jian Zhang,
  • Ling Huang,
  • Jia Xu,
  • Wangjun Yan,
  • Zhongsheng Tong,
  • Da Jiang,
  • Tao Ji,
  • Qiao Li,
  • Ling Xu,
  • Huiying He,
  • Liang Shang,
  • Jin Liu,
  • Kefeng Wang,
  • Duoguang Wu,
  • Jingnan Shen,
  • Ye Liu,
  • Ting Zhang,
  • Chaojie Liang,
  • Yusheng Wang,
  • Yanhong Shang,
  • Jianji Guo,
  • Guanbiao Liang,
  • Shifeng Xu,
  • Junfeng Liu,
  • Kai Wang,
  • Minghui Wang

DOI
https://doi.org/10.1038/s41467-022-31780-9
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 11

Abstract

Read online

Understanding the mutation landscape of cancer may enable the development of more targeted therapies. Here, the authors sequence a panel of genes in a large Asian cohort and compare to American cohorts and find 64% of the Asian patients have actionable mutations.